Entero Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENTO and other ETFs, options, and stocks.About ENTO
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
CEORichard Joel Paolone
CEORichard Joel Paolone
Employees2
Employees2
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2014
Founded2014
Employees2
Employees2
ENTO Key Statistics
Market cap1.91M
Market cap1.91M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume480.05K
Average volume480.05K
High today$0.4215
High today$0.4215
Low today$0.362
Low today$0.362
Open price$0.3699
Open price$0.3699
Volume157.43K
Volume157.43K
52 Week high$1.29
52 Week high$1.29
52 Week low$0.185
52 Week low$0.185
People also own
Based on the portfolios of people who own ENTO. This list is generated using Robinhood data, and it’s not a recommendation.